DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Condition:   Lymphoma, Non-Hodgkin Intervention:   Drug: DZD8586 Sponsor:   Dizal Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials